Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Page Menu

News

  • Monday, June 15, 2020 Greater Worcester COVID-19 Community Health Survey underway

    Greater Worcester COVID-19 Community Health Survey underway

    By: Sandra Gray

    Category: Graduate School of Biomedical Sciences,School of Medicine,Employee,Faculty,Research,Novel Coronavirus

    UMass Medical School is conducting a community-facing survey in Worcester and six surrounding communities to assess how COVID-19 has affected ongoing day-to-day needs and help localities target relief efforts.

  • Friday, June 12, 2020 Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars

    Katherine Fitzgerald and Anastasia Khvorova named Harrington Scholars

    Category: Graduate School of Biomedical Sciences,School of Medicine,Medicine,Office of Advancement,Faculty,Research,Novel Coronavirus,Fitzerald Lab,RNA Therapeutics Institute

    The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT Cures, has chosen two UMass Medical School faculty members to receive Harrington Scholar Awards for Coronavirus.

  • Friday, June 05, 2020 UMass Medical School and UMass Memorial create risk scoring tool to triage COVID-19 patients

    UMass Medical School and UMass Memorial create risk scoring tool to triage COVID-19 patients

    By: Sandra Gray

    Category: Graduate School of Biomedical Sciences,School of Medicine,Office of Advancement,Clinician,Faculty,Student,Research,MD/PhD,Novel Coronavirus

    David McManus, MD, and MD/PhD candidate Apurv Soni developed a tool to predict risk of severe illness in COVID-19 patients.

  • Wednesday, May 27, 2020 UMass Medical School researchers ramp up COVID-19 convalescent plasma study

    UMass Medical School researchers ramp up COVID-19 convalescent plasma study

    By: Susan E.W. Spencer

    Category: Graduate School of Biomedical Sciences,School of Medicine,Cancer Center,Office of Advancement,Clinician,Faculty,Research,Jonathan M. Gerber,Novel Coronavirus

    More than 100 critically ill COVID-19 patients in the UMass Memorial Health Care system have been treated with convalescent plasma through a UMass Medical School clinical trial led by Jonathan M. Gerber, MD.

  • Monday, May 18, 2020 Virus-like particles developed for RSV may hold key to COVID-19 vaccine, UMMS researcher says

    Virus-like particles developed for RSV may hold key to COVID-19 vaccine, UMMS researcher says

    By: Susan E.W. Spencer

    Category: Graduate School of Biomedical Sciences,School of Medicine,Office of Advancement,Faculty,Research,Novel Coronavirus

    Trudy Morrison, PhD, is the featured speaker at the Hudson Hoagland Society’s 35th annual meeting, to be held virtually on Wednesday, May 20.

  • Wednesday, May 13, 2020 Mass Consortium on Pathogen Readiness awards COVID-19 research funding to three UMass Medical School projects

    Mass Consortium on Pathogen Readiness awards COVID-19 research funding to three UMass Medical School projects

    By: Mark Shelton

    Category: Graduate School of Biomedical Sciences,School of Medicine,Office of Advancement,Clinician,Faculty,Research,Novel Coronavirus

    Research into COVID-19 by UMass Medical School scientists Ann Moormann, PhD, MPH; Robert Finberg, MD; and Jeremy Luban, MD, is being funded by the Massachusetts Consortium on Pathogen Readiness.

  • Friday, May 01, 2020 NIH invests in rapid innovation and development for COVID-19 testing

    NIH invests in rapid innovation and development for COVID-19 testing

    Category: Graduate School of Biomedical Sciences,School of Medicine,Office of Advancement,Clinician,Faculty,Research,Novel Coronavirus

    The Center for Advancing Point of Care Technologies, co-directed by David McManus, MD, at UMass Medical School, will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies.

  • Friday, May 01, 2020 Telegram: Robert Finberg explains UMass Medical School role in promising COVID-19 drug trial

    Telegram: Robert Finberg explains UMass Medical School role in promising COVID-19 drug trial

    Category: School of Medicine,Office of Advancement,Clinician,Faculty,Research,Novel Coronavirus

    Thirty-one patients with severe COVID-19 were enrolled in the randomized, controlled trial of the drug remdesivir at UMass Memorial Medical Center’s University and Memorial campuses, overseen by lead investigator Robert W. Finberg, MD.

  • Thursday, April 09, 2020 Fujifilm announces a Phase II clinical trial of influenza antiviral drug for COVID-19

    Fujifilm announces a Phase II clinical trial of influenza antiviral drug for COVID-19

    Category: School of Medicine,Office of Advancement,Clinician,Faculty,Research,Novel Coronavirus

    Fujifilm Corporation announced the initiation of a Phase II clinical trial in the United States to evaluate the safety and efficacy of its antiviral drug Avigan for patients with COVID-19, in collaboration with Brigham and Women’s Hospital, Massachusetts General Hospital and UMass Medical School. Robert W. Finberg, MD, is the principal investigator for the UMMS site.